Početna › Veliki depresivni poremećaj › Connecticut
Kliničke studije za Veliki depresivni poremećaj u državi Connecticut
16 studija za Veliki depresivni poremećaj traži sudionike na lokacijama u državi Connecticut.
Gradovi u državi Connecticut
Službeni tekst studije (engleski)
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- UConn Health Center, Farmington
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Connecticut Health Center, Farmington
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Cromwell
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07065240A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Institute of Living, Hartford
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07076407A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Yale University School of Medicine, New Haven
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 6. kol 2026. · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Ct Clinical Research Associates, Cromwell
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- University of Connecticut School of Medicine Psychiatry Department, Farmington
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06547489A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, New Haven
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cromwell
- Neurocrine Clinical Site, Farmington
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT06966401The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- VA Connecticut Healthcare System, West Haven
U tijeku regrutacijaFaza 2
Od 21 do 65 godina · Oba spola · Ažurirano 6. svi 2026. · NCT05786066Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
- Yale University, New Haven
U tijeku regrutacijaFaza 1
Od 18 do 60 godina · Oba spola · Ažurirano 6. svi 2026. · NCT05915013Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- Hartford Hospital, Hartford
U tijeku regrutacijaOpažajna studija
Od 18 do 40 godina · Oba spola · Ažurirano 10. ožu 2026. · NCT06740383Imaging Depression in Parkinson's Disease
- Yale University, New Haven
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
Od 40 do 80 godina · Oba spola · Ažurirano 10. ožu 2026. · NCT06402955Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #122, Cromwell
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 20. sij 2026. · NCT06633016Study of ALTO-300 in MDD
- Site 214, Norwalk
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 24. srp 2025. · NCT05922878Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.